Making hypoxic metabolism visible for 64Cu-ATSM treatment using simultaneous PET/SPECT imaging

Making hypoxic metabolism visible for 64Cu-ATSM treatment using simultaneous PET/SPECT imaging

by Prof. Dr. Yasuhisa Fujibayashi, National Institute of Radiological Sciences, School of Medicine, Keio University, Japan

Exploit simultaneous 99mTc-HSA/64Cu-ATSM imaging to accelerate the development of 64Cu-ATSM as an add-on targeted radiotherapy agent.


You may also like

Bart Cornelissen imaging DNA damage webinar thumbnail
Each DNA damage repair pathway leads to the recruitment, upregulation, or activation of specific proteins within the nucleus, which, in some cases, can represent attractive targets for molecular imaging.
webinar thumnail Marko Rosenholm
Marko Rosenholm presents some of the findings and results regarding dynamic SPECT/CT imaging of a glymphatic system they have acquired with the MILabs VECTor/CT system.
Bruce Hasegawa Memorial Lecture 2021
This annual lecture honors the legacy of Dr. Bruce Hasegawa. MILabs’ Founder and CEO, Prof. Freek Beekman, presents the 2021 Bruce Hasegawa Memorial Lecture at the University of California, San Francisco. In this video presentation, he talks about the physics, engineering, and application of Fully Integrated Ultra-High Definition Optical Tomography, PET, SPECT & X-ray CT.
Scroll to Top